Following FDA COVID vaccine advisory panel vote, Novavax is prepared to provide a revised vaccine

Novavax is prepared to deliver an updated vaccine following FDA guidance on strain change. The process of making a new, variant-specific vaccine would take about six months but cannot compete on speed with mRNA. But a company spokesperson stated that ensuring the availability and accessibility of various vaccine options should be a central focus in any strategy aimed at safeguarding public health against Covid-19.